PhRMA CEO Stephen Ubl at #JPM23 (Adrien Villez for Endpoints News)
PhRMA calls document destruction part of new guidance on drug price negotiations 'unconstitutional'
Many have wondered how the biopharma industry might take CMS to court over its new drug price negotiations plans, and lobbying group PhRMA offered a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.